Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present ArQule, Inc. (NASDAQ: ARQL).

Full DD Report for ARQL

You must become a subscriber to view this report.


Recent News from (NASDAQ: ARQL)

Reader Inquiry: Time To Buy EyeGate Pharmaceuticals?
Shares of struggling biotech EyeGate Pharmaceuticals ( EYEG ) have fallen by nearly 70% over the past year. However, the stock has risen 17% year to date as the current move appears to have legs. The stock popped back onto my radar in late April when one member in Live Chat pointed out signi...
Source: SeekingAlpha
Date: May, 18 2018 00:05
After Hours Gainers / Losers (05/17/2018)
Top gainers:   QTNT   +12.1% .  AFSI +6.1% . EIGR   +3.5% . DRNA +3.0% . TIVO   +2.0% . More news on: Quotient Limited, AmTrust Financial Services, Inc., Eiger BioPharmaceuticals, Inc., Stocks on the move, , News on ETFs, Read more ...
Source: SeekingAlpha
Date: May, 17 2018 17:35
ArQule -6.3% as it registers 10.6M shares for selling holders
ArQule (NASDAQ: ARQL ) is 6.3% lower in postmarket trade after it filed a registration statement for up to 10.629M shares for sale by certain stockholders. More news on: ArQule, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Source: SeekingAlpha
Date: May, 17 2018 17:24
ArQule's (ARQL) CEO Paolo Pucci on Q1 2018 Results - Earnings Call Transcript
ArQule, Inc. (ARQL) Q1 2018 Earnings Conference Call May 7, 2018 09:00 AM ET Executives Dawn Schottlandt - VP, Investor Relations Peter Lawrence - President and Chief Operating Officer Paolo Pucci - CEO Brian Schwartz - Head of Research and Development Rob Weiskopf - CFO A...
Source: SeekingAlpha
Date: May, 07 2018 15:43
ArQule misses by $0.01, beats on revenue
ArQule (NASDAQ: ARQL ): Q1 EPS of -$0.07 misses by $0.01 . More news on: ArQule, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: May, 07 2018 07:01
ArQule Reports First Quarter 2018 Financial Results
Conference call scheduled today at 9:00 a.m. ET ArQule , Inc. (Nasdaq: ARQL) today announced its financial results for the first quarter of 2018. For the quarter ended March 31, 2018, the Company reported a net loss of $6,532,000, or $0.07 per share, compared with net loss of $7,...
Source: Business Wire
Date: May, 07 2018 07:00
After Hours Gainers / Losers (04/27/2018)
Top gainers:   TZOO   +2.8% .  ARQL +2.2% . EBIO +2.0% . FHB   +1.6% . ATUS   +1.5% . More news on: Travelzoo Inc, ArQule, Inc., Eleven Biotherapeutics, Inc., Stocks on the move, , News on ETFs, Read more ...
Source: SeekingAlpha
Date: April, 27 2018 17:42
ArQule to Report First Quarter 2018 Financial Results on May 7, 2018
ArQule , Inc. (Nasdaq: ARQL) today announced it will report financial results for the first quarter of 2018 before the market opens on Monday, May 7, 2018. The Company will hold a conference call and webcast on the same day at 9:00 a.m. ET to discuss these results and provide a general busi...
Source: Business Wire
Date: April, 23 2018 16:35
Wired News - ArQule Inked Exclusive License Deal with Basilea for Derazantinib in the US, EU, Japan and Rest of World
Stock Monitor: Hemispherx Biopharma Post Earnings Reporting LONDON, UK / ACCESSWIRE / April 19, 2018 / Active-Investors.com has just released a free research report on ArQule, Inc. (NASDAQ: ARQL ). If you want access to this report all you need to do is sign up now by clicking the fo...
Source: ACCESSWIRE IA
Date: April, 19 2018 07:30
ASLAN Pharmaceuticals Updates U.S. IPO Plans
Quick Take ASLAN Pharmaceuticals ( ASLN ) intends to raise $60.4 million from the sale of ADSs in a U.S. IPO . The company targets cancers that are both highly prevalent in Asia and orphan indications in the United States and Europe. ASLN is making excellent progress on its pipeline o...
Source: SeekingAlpha
Date: April, 18 2018 17:49

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-254.565.125.28774.533,684,125
2018-05-244.404.524.674.311,970,749
2018-05-233.994.2954.343.981,638,058
2018-05-223.653.9354.203.533,899,337
2018-05-183.323.453.563.231,473,173

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-05-25660,9811,757,91137.6004Short
2018-05-24389,786910,65342.8029Short
2018-05-23285,450830,23134.3820Cover
2018-05-221,041,7311,939,31153.7166Short
2018-05-21169,467773,84321.8994Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ARQL.


About ArQule, Inc. (NASDAQ: ARQL)

Logo for ArQule, Inc. (NASDAQ: ARQL)

Not available

 

Contact Information

 

 

Current Management

  • David C. Hastings / CFO

Current Share Structure

  • Market Cap: $240,424,158 - 05/11/2018
  • Issue and Outstanding: 87,110,202 - 10/25/2017

 


Recent Filings from (NASDAQ: ARQL)

Simplified registration form
Filing Type: S-3Filing Source: edgar
Filing Date: May, 17 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 07 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 07 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 17 2018
Filing Type: CT ORDERFiling Source: edgar
Filing Date: April, 06 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: March, 29 2018
Preliminary proxy statement providing notification matters to be brought to a vote
Filing Type: PRE 14AFiling Source: edgar
Filing Date: March, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 05 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 05 2018

 

 


Daily Technical Chart for (NASDAQ: ARQL)

Daily Technical Chart for (NASDAQ: ARQL)


Stay tuned for daily updates and more on (NASDAQ: ARQL)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: ARQL)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

OTC Report
@OTCReporter

 

 


Disclaimer: OTC Report publishes reports providing information on selected companies. OTC Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. OTC Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ARQL is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. OTC Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. OTC Report does not own any shares of ARQL and does not buy, sell, or trade any shares of ARQL. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by OTC Report. All rights reserved. Our Full Disclaimer: http://otc.report/disclaimer/